AKT1 and acute respiratory distress syndrome: Among these metabolites, compound 13 was identified as the most active compound with an outstanding ability of anti-LPS-induced inflammation in RAW264.7 macrophages and in ALI mice, probably by inhibiting the PI3K/AKT signaling pathway.